Bridgefront Capital LLC lessened its stake in shares of The Campbell’s Company (NASDAQ:CPB – Free Report) by 53.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 45,216 shares of the company’s stock after selling 52,721 shares during the quarter. Bridgefront Capital LLC’s holdings in Campbell’s were worth $1,428,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Campbell’s by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,472 shares of the company’s stock valued at $777,000 after purchasing an additional 685 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of Campbell’s by 4.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 660,543 shares of the company’s stock worth $26,369,000 after purchasing an additional 27,374 shares in the last quarter. Empowered Funds LLC bought a new position in shares of Campbell’s during the 1st quarter valued at about $446,000. Woodline Partners LP increased its position in shares of Campbell’s by 40.9% during the 1st quarter. Woodline Partners LP now owns 16,623 shares of the company’s stock valued at $664,000 after purchasing an additional 4,827 shares during the last quarter. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Campbell’s by 333.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 975 shares of the company’s stock valued at $39,000 after buying an additional 750 shares in the last quarter. 52.35% of the stock is currently owned by institutional investors.
Campbell’s News Roundup
Here are the key news stories impacting Campbell’s this week:
- Positive Sentiment: Appointment of Joshua Levine as Chief Investor Relations Officer could improve investor communication and help reset expectations. Campbell’s Appoints Joshua Levine Chief Investor Relations Officer
- Positive Sentiment: Sanford C. Bernstein kept an “outperform” stance (though cut its PT), signaling that some analysts still see upside from here. Bernstein Maintains Outperform
- Neutral Sentiment: DA Davidson reaffirmed coverage with a $30 price target, which implies significant upside but keeps a cautious posture. DA Davidson Reaffirms Neutral
- Neutral Sentiment: Several brokers trimmed price targets (Deutsche Bank to $23, Morgan Stanley to $25, Stifel to $25, RBC to $26) and shifted ratings to hold/sector perform — these are mixed signals that reduce near-term upside but stop short of broad sell recommendations. Analyst Price Target Changes
- Negative Sentiment: Q2 results disappointed: EPS missed, revenue fell ~5% Y/Y and organic sales declined ~3%; management lowered FY26 guidance (EPS range 2.15–2.25), prompting analysts to cut forecasts. This is the primary driver of the sell-side reaction. Campbell’s posts one of worst quarters
- Negative Sentiment: UBS moved to a “sell” rating and lowered its target to $20 — a direct negative catalyst because that PT sits below the current market price and signals increased downside from a major broker. UBS Downgrade
- Negative Sentiment: Wells Fargo downgraded CPB as part of a broader caution on packaged-food names, citing inflation, weak consumption and promotional pressure — adds sector-level headwinds to company-specific issues. Wells Fargo Downgrade
- Negative Sentiment: Analysts and market commentators describe the quarter as one of Campbell’s weakest in years; shares already gapped down after the print and analyst model cuts suggest pressure on near-term earnings and dividend coverage. Market Reaction to Weak Quarter
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Campbell’s
Campbell’s Price Performance
CPB opened at $21.71 on Friday. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.01 and a quick ratio of 0.34. The stock’s 50 day simple moving average is $26.76 and its 200 day simple moving average is $29.35. The firm has a market cap of $6.47 billion, a price-to-earnings ratio of 11.86, a PEG ratio of 8.42 and a beta of -0.03. The Campbell’s Company has a 1 year low of $21.59 and a 1 year high of $40.59.
Campbell’s (NASDAQ:CPB – Get Free Report) last announced its quarterly earnings data on Wednesday, March 11th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.06). The company had revenue of $2.56 billion during the quarter. Campbell’s had a net margin of 5.48% and a return on equity of 19.96%. The business’s revenue was down 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.74 EPS. Campbell’s has set its FY 2026 guidance at 2.150-2.250 EPS. As a group, analysts predict that The Campbell’s Company will post 3.15 earnings per share for the current year.
Campbell’s Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 2nd will be given a dividend of $0.39 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.56 annualized dividend and a yield of 7.2%. Campbell’s’s dividend payout ratio is presently 85.25%.
Insider Buying and Selling at Campbell’s
In other Campbell’s news, EVP Charles A. Brawley III sold 11,550 shares of the firm’s stock in a transaction on Tuesday, December 30th. The shares were sold at an average price of $28.14, for a total value of $325,017.00. Following the sale, the executive vice president owned 43,777 shares of the company’s stock, valued at $1,231,884.78. This trade represents a 20.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Anthony Sanzio sold 2,700 shares of the business’s stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $26.51, for a total transaction of $71,577.00. Following the completion of the transaction, the executive vice president owned 25,264 shares in the company, valued at $669,748.64. The trade was a 9.66% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 19.78% of the company’s stock.
Campbell’s Company Profile
Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.
The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.
Featured Stories
- Five stocks we like better than Campbell’s
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Want to see what other hedge funds are holding CPB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Campbell’s Company (NASDAQ:CPB – Free Report).
Receive News & Ratings for Campbell's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Campbell's and related companies with MarketBeat.com's FREE daily email newsletter.
